The difference between dacomitinib and afatinib in effectiveness and safety in first-line treatment of patients with advanced EGFR-mutant non-small cell lung cancer: a real-world observational study

被引：0
|
作者：
Wen-Chien Cheng
Chi-Chien Lin
Wei-Chih Liao
Yu-Chao Lin
Chia-Hung Chen
Hung-Jen Chen
Chih-Yen Tu
Te-Chun Hsia
机构：
[1] China Medical University Hospital,Division of Pulmonary and Critical Care, Department of Internal Medicine
[2] China Medical University,School of Medicine, College of Medicine
[3] National Chung Hsing University,Department of Life Science
[4] National Chung Hsing University,PhD Program in Translational Medicine
[5] National Chung Hsing University,Rong Hsing Research Center for Translational Medicine
[6] National Chung-Hsing University,Institute of Biomedical Science, the iEGG and Animal Biotechnology Center, Advanced Plant and Food Crop Biotechnology Center
[7] Kaohsiung Medical University,Department of Pharmacology, College of Medicine
[8] Taichung Veterans General Hospital,Department of Medical Research
来源：
BMC Cancer | / 24卷
关键词：
Non-small cell lung cancer (NSCLC); Epidermal growth factor receptor (EGFR); Dacomitinib; Afatinib;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] CNS efficacy of afatinib as first-line treatment in advanced non-small cell lung cancer patients with EGFR mutations
    Kang, Liping
    Mai, Jianliang
    Liang, Weiting
    Zou, Qihua
    Huang, Caiwen
    Lin, Yongbin
    Liang, Ying
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [32] First-line Afatinib for Non-Small Cell Lung Cancer in Real World Practice
    Kim, Y.
    Sun, J.
    Park, K.
    Park, S. E.
    Lee, S.
    Ahn, M.
    Ahn, J. S.
    Lim, S. W.
    Lee, H.
    Cho, J. H.
    Kim, H. K.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2209 - S2209
  • [33] Overall Survival of Advanced Non-Small Cell Lung Cancer Treated with First-Line Afatinib: A Multicenter Real-World Study in Vietnam
    Pham, C. T. M.
    Truong, M. C.
    Do, T. A.
    Pham, P. C.
    Nguyen, H. T. T.
    Nguyen, K. T.
    Hoang, T. T. A.
    Le, A. T.
    Vuong, H. D. T.
    Nguyen, T. D. N.
    Dang, K. V.
    Nguyen, O. T.
    Luan, P. V.
    Nguyen, H. M.
    Vo, T. T. H.
    Do, K. H.
    Vu, T. H.
    Nguyen, H. T. T.
    Pham, T. V.
    Trinh, H. L.
    Nguyen, G. H.
    Nguyen, P. T. B.
    JOURNAL OF THORACIC ONCOLOGY, 2024, 19 (10) : S630 - S631
  • [34] Comparative effects of afatinib and gefitinib as first-line treatment in patients with advanced stage non-small cell lung cancer with common Egfr mutations: Real-world data on PFS
    Luan Pham
    Tung Nguyen
    Hai Nguyen
    Tien Nguyen
    Tien Nguyen
    RESPIROLOGY, 2023, 28 : 117 - 117
  • [35] A real-world study of dacomitinib in later-line settings for advanced non-small cell lung cancer patients harboring EGFR mutations
    Li, Hong-Shuai
    Zhang, Jin-Yao
    Yan, Xiang
    Xu, Hai-Yan
    Hao, Xue-Zhi
    Xing, Pu-Yuan
    Wang, Yan
    CANCER MEDICINE, 2022, 11 (04): : 1026 - 1036
  • [36] Real-World Case Series on Efficacy and Safety of Amivantamab for EGFR-mutant Non-small Cell Lung Cancer
    Le, X.
    Du, R.
    Lewis, W. E.
    Hong, L.
    Skoulidis, F.
    Byers, L.
    Tsao, A.
    Cascone, T.
    Pozadzides, J.
    Tu, J.
    Negrao, M. V.
    Baik, C.
    Zhang, J.
    Heymach, J.
    JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) : S484 - S484
  • [37] Dacomitinib for the first-line treatment of patients with EGFR-mutated metastatic non-small cell lung cancer
    Santarpia, Mariacarmela
    Menis, Jessica
    Chaib, Imane
    Cao, Maria Gonzalez
    Rosell, Rafael
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2019, 12 (09) : 831 - 840
  • [38] Real-world first-line afatinib for advanced EGFR mutation-positive non-small cell lung cancer in Korea: updated survival data
    Choi, Juwhan
    Choi, Chang Min
    Chang, Yoon Soo
    Lee, Kye Young
    Kim, Seung Joon
    Yang, Sei Hoon
    Ryu, Jeong Seon
    Lee, Jeong Eun
    Lee, Shin Yup
    Park, Ji Young
    Kim, Young-Chul
    Oh, In-Jae
    Jung, Chi Young
    Lee, Sang Hoon
    Yoon, Seong Hoon
    Lee, Sung Yong
    Jang, Tae Won
    TRANSLATIONAL LUNG CANCER RESEARCH, 2023, 12 (11) : 2275 - 2282
  • [39] Single-Center Real-World Study of First Line Afatinib Treatment in Advanced EGFR-mutated Non-small Cell Lung Cancer in Vietnam
    Pham, C. T. M.
    Hoang, T. T. A.
    Truong, P. T.
    Bui, P. T. T.
    Nguyen, T. T.
    Vo, T. N.
    Tran, D. T.
    Nguyen, D. T.
    Tran, T. X.
    Le, H. H.
    Dong, H. Q.
    Nguyen, K. T.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S662 - S663
  • [40] Multicentered Real-World Evidence of Osimertinib Treatment in EGFR-Mutant Advanced Non-Small Cell Lung Cancer (NSCLC) In Thailand
    Thamrongjirapat, T.
    Sitthideatphaiboon, P.
    Oranratnachai, S.
    Khiewngam, K.
    Maneenil, K.
    Prasongsook, N.
    Korphaisarn, K.
    Wangsubtawee, S.
    Rattanaphom, A.
    Reungwetwattana, T.
    Sriuranpong, V.
    JOURNAL OF THORACIC ONCOLOGY, 2024, 19 (10) : S624 - S625
12345